AFFINITY

The holiday season tends to make December feel like it's gone by in an instant, so many traders are already starting to gear up for the New Year. Since the Federal Reserve's upcoming policy meeting has the potential to upset markets in the coming week, many have already begun to craft their wish-...

Shares of OncoGenex Pharmaceuticals Inc (NASDAQ: OGXI) plunged more than 30 percent on Wednesday. OncoGenex said that its Phase 3 AFFINITY trial with custirsen is continuing following an interim analysis. Stephen Willey of Stifel downgraded shares of OncoGenex to Hold despite shares trading at/...